Neurowave Medical Technologies LLC Launches Nometex(TM) - A Unique Neuromodulation Device to Treat Chemotherapy-Induced Nausea and Vomiting
7/7/2011 9:29:41 AM
Neurowave Medical Technologies™ (NMT) introduced Nometex™, a new transdermal neuromodulation device to treat patients with chemotherapy-induced nausea and vomiting (CINV), at the 2011 scientific meeting of the American Society of Clinical Oncology (ASCO). Nometex was designed to improve the quality of life for the more than 1.2 million Americans who undergo chemotherapy-radiation treatments each year. Its innovative approach to delivering continuous protection against CINV -- one of most feared side effects of chemotherapy -- garnered enthusiastic professional response at ASCO. Renowned oncologists recognized the clinical efficacy of the drug-free solution, along with its potential to reduce morbidity and cost of therapy.
comments powered by